Profile - To The Moon

DENnCAR

Posts · 13Posts · 13
Following · 0Following · 0
Followers · 0Followers · 0

- DENnCARDENnCAR
  ·2022-04-22
  👋
  WHO Backs Pfizer's Paxlovid for Certain COVID Patients but Raises Concerns on Drug Access, Pricing
  The World Health Organization (WHO) recommended the use of Pfizer's (NYSE:PFE) antiviral pill Paxlov
  WHO Backs Pfizer's Paxlovid for Certain COVID Patients but Raises Concerns on Drug Access, Pricing
  1.53K Comment
  1
  Share
  Report
- DENnCARDENnCAR
  ·2022-04-16
  Nice game
  🏆【GAME】Hunting Eggs for Extra Saving!
  @TigerEvents：
  Tiger has prepared some Easter gifts for you, please click here to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien
  🏆【GAME】Hunting Eggs for Extra Saving!
  891 Comment
  Like
  Share
  Report
- DENnCARDENnCAR
  ·2022-01-10
  [smile]
  Sorry, this post has been deleted
  1.92K Comment
  2
  Share
  Report
- DENnCARDENnCAR
  ·2021-08-19
  ???
  1.31K Comment
  Like
  Share
  Report
- DENnCARDENnCAR
  ·2021-05-27
  Omg
  Beyond Meat shares surges nearly 10%
  Beyond Meat shares surges nearly 10%.For the first quarter of 2021, Beyond Meat saw 11.4% year-over-
  Beyond Meat shares surges nearly 10%
  1.89K 1
  2
  Share
  Report
- DENnCARDENnCAR
  ·2021-05-12
  Down
  Sorry, this post has been deleted
  2.08K 2
  2
  Share
  Report
- DENnCARDENnCAR
  ·2021-04-30
  Omg
  Sorry, this post has been deleted
  1.52K Comment
  1
  Share
  Report
- DENnCARDENnCAR
  ·2021-04-01
  Good
  Sorry, this post has been deleted
  1.60K Comment
  1
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3567699591558583","uuid":"3567699591558583","gmtCreate":1604606930392,"gmtModify":1604606930392,"name":"DENnCAR","pinyin":"denncar","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":23,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.05","exceedPercentage":"93.33%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9085029597,"gmtCreate":1650621254251,"gmtModify":1676534765207,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"👋&nbsp;","listText":"👋&nbsp;","text":"👋","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9085029597","repostId":"1134510967","repostType":4,"repost":{"id":"1134510967","kind":"news","pubTimestamp":1650619829,"share":"https://ttm.financial/m/news/1134510967?lang=en_US&edition=fundamental","pubTime":"2022-04-22 17:30","market":"us","language":"en","title":"WHO Backs Pfizer's Paxlovid for Certain COVID Patients but Raises Concerns on Drug Access, Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=1134510967","media":"Seeking Alpha","summary":"The World Health Organization (WHO) recommended the use of Pfizer's (NYSE:PFE) antiviral pill Paxlov","content":"<html><head></head><body><p>The World Health Organization (WHO) recommended the use of Pfizer&#39;s (NYSE:PFE) antiviral pill Paxlovid to treat patients with mild and moderate COVID-19 who are at the highest risk of hospital admission.</p><p>The WHO suggested against not to use the drug in patients at lower risk, as the benefits were found to be negligible, the agency said in an April 22 press release.</p><p>The WHO called the drug &#39;best therapeutic choice for high-risk patients to date&#39; but noted that availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before administering it, are turning the therapy into a major challenge for low- and middle-income countries.</p><p>The agency said Paxlovid (a combination of nirmatrelvir and ritonavir) was recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such those not vaccinated, older or immunosuppressed patients.</p><p>The recommendation was backed by new data from two trials involving 3,078 patients. The data showed that the risk of hospitalization reduced by 85% after taking the drug.</p><p>The WHO, however, noted that it was concerned that — as occurred with COVID-19 vaccines — low- and middle-income countries will again be pushed to the end of the line when in terms of access to the therapy.</p><p>Lack of transparency on the part of the originator company was making it difficult for public health organizations to get accurate information on the availability of the drug, which countries are involved in bilateral deals and the price they are paying for the drug, the agency added.</p><p>In addition, the WHO noted that a licensing agreement made by Pfizer with the Medicines Patent Pool has limited the number of countries that can benefit from generic production of the drug.</p><p>The agency said Paxlovid, will be included in the WHO prequalification list but its generic is not yet available. Several generic companies (several of which are covered by the licensing deal between Pfizer and Medicines Pool) are in discussion with WHO Prequalification but may take time to comply with international standards to supply the drug internationally.</p><p>WHO urged Pfizer to make its pricing and deals more transparent and to enlarge the geographical scope of the license with the Medicines Patent Pool so that more generic drugmakers may start to produce the therapy and make it available at affordable prices.</p><p>In March, it was reported that Pfizer (PFE) was expected to provide ~10M courses of Paxlovid to low and middle-income nations in 2022. Separately, Pfizer had agreed to supply Paxlovid to Africa Centres for Disease Control and Prevention.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WHO Backs Pfizer's Paxlovid for Certain COVID Patients but Raises Concerns on Drug Access, Pricing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWHO Backs Pfizer's Paxlovid for Certain COVID Patients but Raises Concerns on Drug Access, Pricing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-22 17:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3825662-who-backs-pfizers-paxlovid-in-high-risk-covid-patients-but-raises-concerns-on-drug-access-pricing><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The World Health Organization (WHO) recommended the use of Pfizer's (NYSE:PFE) antiviral pill Paxlovid to treat patients with mild and moderate COVID-19 who are at the highest risk of hospital ...</p>\n\n<a href=\"https://seekingalpha.com/news/3825662-who-backs-pfizers-paxlovid-in-high-risk-covid-patients-but-raises-concerns-on-drug-access-pricing\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://seekingalpha.com/news/3825662-who-backs-pfizers-paxlovid-in-high-risk-covid-patients-but-raises-concerns-on-drug-access-pricing","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134510967","content_text":"The World Health Organization (WHO) recommended the use of Pfizer's (NYSE:PFE) antiviral pill Paxlovid to treat patients with mild and moderate COVID-19 who are at the highest risk of hospital admission.The WHO suggested against not to use the drug in patients at lower risk, as the benefits were found to be negligible, the agency said in an April 22 press release.The WHO called the drug 'best therapeutic choice for high-risk patients to date' but noted that availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before administering it, are turning the therapy into a major challenge for low- and middle-income countries.The agency said Paxlovid (a combination of nirmatrelvir and ritonavir) was recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such those not vaccinated, older or immunosuppressed patients.The recommendation was backed by new data from two trials involving 3,078 patients. The data showed that the risk of hospitalization reduced by 85% after taking the drug.The WHO, however, noted that it was concerned that — as occurred with COVID-19 vaccines — low- and middle-income countries will again be pushed to the end of the line when in terms of access to the therapy.Lack of transparency on the part of the originator company was making it difficult for public health organizations to get accurate information on the availability of the drug, which countries are involved in bilateral deals and the price they are paying for the drug, the agency added.In addition, the WHO noted that a licensing agreement made by Pfizer with the Medicines Patent Pool has limited the number of countries that can benefit from generic production of the drug.The agency said Paxlovid, will be included in the WHO prequalification list but its generic is not yet available. Several generic companies (several of which are covered by the licensing deal between Pfizer and Medicines Pool) are in discussion with WHO Prequalification but may take time to comply with international standards to supply the drug internationally.WHO urged Pfizer to make its pricing and deals more transparent and to enlarge the geographical scope of the license with the Medicines Patent Pool so that more generic drugmakers may start to produce the therapy and make it available at affordable prices.In March, it was reported that Pfizer (PFE) was expected to provide ~10M courses of Paxlovid to low and middle-income nations in 2022. Separately, Pfizer had agreed to supply Paxlovid to Africa Centres for Disease Control and Prevention.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9083168498,"gmtCreate":1650080013133,"gmtModify":1676534643585,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"Nice game","listText":"Nice game","text":"Nice game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083168498","repostId":"9016476123","repostType":1,"repost":{"id":9016476123,"gmtCreate":1649229403658,"gmtModify":1676534474180,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667667103859","idStr":"3527667667103859"},"themes":[],"title":"🏆【GAME】Hunting Eggs for Extra Saving!","htmlText":"Tiger has prepared some Easter gifts for you, please&nbsp;<a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/easter/\" target=\"_blank\">click&nbsp;here</a>&nbsp;to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien","listText":"Tiger has prepared some Easter gifts for you, please&nbsp;<a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/easter/\" target=\"_blank\">click&nbsp;here</a>&nbsp;to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien","text":"Tiger has prepared some Easter gifts for you, please click here to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien","images":[{"img":"https://community-static.tradeup.com/news/15b435c0d10e0e89ad3e06b7bbd04830","width":"2251","height":"1334"},{"img":"https://community-static.tradeup.com/news/ff9640a9df2f24446e07b7a9b658cb4b","width":"1200","height":"630"},{"img":"https://community-static.tradeup.com/news/795038848b7c7b1d7dda27d92b580946","width":"1656","height":"948"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016476123","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":891,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006240624,"gmtCreate":1641772373458,"gmtModify":1676533646118,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"[smile]&nbsp;","listText":"[smile]&nbsp;","text":"[smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006240624","repostId":"1156839888","repostType":4,"isVote":1,"tweetType":1,"viewCount":1921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831508437,"gmtCreate":1629332976429,"gmtModify":1676530004521,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[{"img":"https://static.tigerbbs.com/a5788cb45449167783b95180629d0226","width":"1080","height":"3022"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/831508437","isVote":1,"tweetType":1,"viewCount":1307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":135053191,"gmtCreate":1622123499013,"gmtModify":1704179893157,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/135053191","repostId":"1188393893","repostType":4,"repost":{"id":"1188393893","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622123328,"share":"https://ttm.financial/m/news/1188393893?lang=en_US&edition=fundamental","pubTime":"2021-05-27 21:48","market":"us","language":"en","title":"Beyond Meat shares surges nearly 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188393893","media":"Tiger Newspress","summary":"Beyond Meat shares surges nearly 10%.For the first quarter of 2021, Beyond Meat saw 11.4% year-over-","content":"<p>Beyond Meat&nbsp;shares&nbsp;surges&nbsp;nearly&nbsp;10%.</p><p><img src=\"https://static.tigerbbs.com/a34ea5683a321e8be4e74d066f19af12\" tg-width=\"810\" tg-height=\"610\" referrerpolicy=\"no-referrer\">For the first quarter of 2021, Beyond Meat saw 11.4% year-over-year (YOY) revenue growth despite the domestic foodservice segment being down 26% YOY. The reduction in the restaurant business drives the decrease in the foodservice segment, and Beyond Meat should see stronger results as restaurants begin to reopen domestically and internationally.</p><p>Looking through Beyond Meat's investor relations press release, the company has announced numerous partnerships. To name a few, in the past three months it has increased its products in&nbsp;<b>Walmart</b>, partnered up with&nbsp;<b>Pizza Hut</b>Canada and Carl's Jr., announced major retail expansions throughout Europe, and opened up a manufacturing facility in China.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Meat shares surges nearly 10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Meat shares surges nearly 10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-27 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beyond Meat&nbsp;shares&nbsp;surges&nbsp;nearly&nbsp;10%.</p><p><img src=\"https://static.tigerbbs.com/a34ea5683a321e8be4e74d066f19af12\" tg-width=\"810\" tg-height=\"610\" referrerpolicy=\"no-referrer\">For the first quarter of 2021, Beyond Meat saw 11.4% year-over-year (YOY) revenue growth despite the domestic foodservice segment being down 26% YOY. The reduction in the restaurant business drives the decrease in the foodservice segment, and Beyond Meat should see stronger results as restaurants begin to reopen domestically and internationally.</p><p>Looking through Beyond Meat's investor relations press release, the company has announced numerous partnerships. To name a few, in the past three months it has increased its products in&nbsp;<b>Walmart</b>, partnered up with&nbsp;<b>Pizza Hut</b>Canada and Carl's Jr., announced major retail expansions throughout Europe, and opened up a manufacturing facility in China.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BYND":"Beyond Meat, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188393893","content_text":"Beyond Meat shares surges nearly 10%.For the first quarter of 2021, Beyond Meat saw 11.4% year-over-year (YOY) revenue growth despite the domestic foodservice segment being down 26% YOY. The reduction in the restaurant business drives the decrease in the foodservice segment, and Beyond Meat should see stronger results as restaurants begin to reopen domestically and internationally.Looking through Beyond Meat's investor relations press release, the company has announced numerous partnerships. To name a few, in the past three months it has increased its products in Walmart, partnered up with Pizza HutCanada and Carl's Jr., announced major retail expansions throughout Europe, and opened up a manufacturing facility in China.","news_type":1,"symbols_score_info":{"BYND":0.9}},"isVote":1,"tweetType":1,"viewCount":1887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":193681640,"gmtCreate":1620784082380,"gmtModify":1704348323104,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"Down&nbsp;","listText":"Down&nbsp;","text":"Down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/193681640","repostId":"2134698127","repostType":4,"isVote":1,"tweetType":1,"viewCount":2075,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103291808,"gmtCreate":1619784575704,"gmtModify":1704272311264,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103291808","repostId":"1178555518","repostType":4,"isVote":1,"tweetType":1,"viewCount":1518,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":357345653,"gmtCreate":1617241504872,"gmtModify":1704697686127,"author":{"id":"3567699591558583","authorId":"3567699591558583","name":"DENnCAR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567699591558583","idStr":"3567699591558583"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357345653","repostId":"1196818239","repostType":4,"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}